IQVIA™ Real-World Insights Bibliography

Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data
Author(s): Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer, Philip Levin
Affiliations(s): Huan Huang, IQVIA
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling.
Author(s): Ramos M, Foos V, McEwan P, Lamotte M
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s):  ISPOR 20th Annual European Congress, 2017, November 4-8, Glasgow, Scotland
Document Type(s): Poster,
Countries: USA,
C:
Y:
Diabetes, Health economics,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease
Author(s): Huan Huang, Sharash Shetty, Elise Bauer, Kathleen Lang
Affiliations(s): Huan Huang, IQVIA
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Child growth and development outcomes following in-utero exposure to metformin versus insulin for treatment of gestational diabetes.
Author(s): Landi SN, Radke S, Engel SM, Sturmer T, Boggess K, Howe A, Jonsson Funk M
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018: 27 (2):351-351.
Document Type(s): 
Countries: 
C:
Y:
Diabetes,
2018
  L:
A:
English
  Add to report
 
 
A Retrospective Real-World Study of Dapagliflozin Versus Other Oral Antidiabetic Therapies Added to Metformin in Patients with Type 2 Diabetes (T2D).
Author(s): Huang H, Bell K, Gani R, Tugwell C, Eudicone J, Krukas‐Hampel MR
Affiliations(s): Huan Huang is at IQVIA
Publication(s):  Am J Manag Care
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Diabetes,
2018
  L:
A:
English
Population Based Study,
  Add to report
 
 
"Risk of chronic kidney disease in young adults with impaired glucose tolerance/ impaired fasting glucose: a retrospective cohort study using electronic primary care records"
Author(s): Ferozkhan Jadhakhan, Tom Marshall, Ronan Ryan and Paramjit Gill.
Affiliations(s): University of Birmingham
Publication(s): 
Document Type(s): Article,
Countries: UK,
C:
Y:
Diabetes,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Author(s): Bodaghi Charles, Benque Emma, Troubat Arnaud
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France, Germany, Spain, UK,
C:
Y:
Diabetes,
2018
  L:
A:
English
Clinical setting: Home care, Pricing & Reimbursement,
  Add to report
 
 
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Author(s): Palmer AJ1, Si L1, Tew M2, Hua X2, Willis MS3, Asseburg C3, McEwan P4, Leal J5, Gray A5, Foos V6, Lamotte M6, Feenstra T7, 8, O’Connor PC 9, Brandle M 10, Smolen HJ11, Gahn JC11, Valentine WJ12, Pollock RF12, Breeze P13, Brennan A13, Pollard D13, Ye W14, Herman WH15, Isaman DJ14, Kuo S16, Laiteerapong N17, Tran-Duy A2, Clarke PM2
Affiliations(s): 1 University of Tasmania, Hobart, Tasmania, Australia 2 University of Melbourne, Melbourne, Victoria, Australia 3 The Swedish Institute for Health Economics, Lund, Sweden 4 Health Economics and Outcomes Research Ltd., Cardiff, UK 5 University of Oxford, Oxford, UK 6 IQVIA, Zaventem, Belgium 7 National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 8 Groningen University, Groningen, The Netherlands 9 HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA 10 Kantonsspital St. Gallen, St. Gallen, Switzerland 11 Medical Decision Modeling Inc., Indianapolis, IN, USA 12 Ossian Health Economics and Communications, Basel, Switzerland 13 University of Sheffield, Sheffield, UK 14 University of Michigan, Ann Arbor, MI, USA 15 University of Michigan, Ann Arbor, MI, USA 16 University of Michigan, Ann Arbor, MI, USA 17 University of Chicago, Chicago, IL, USA
Publication(s):  Value in Health, 2018, 21(6): 724-731
Document Type(s): Article,
Countries: International,
Click here for the abstract
C:
Y:
Diabetes, Health economics,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations.
Author(s): Foos V, McEwan P, Lamotte M
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s):  Value in Health, Volume 21, Supplement 1, May 2018, Page S220
Document Type(s): Poster,
Countries: USA,
C:
Y:
Diabetes, Health economics,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Changes in Patient Characteristics, Glucose Lowering Treatment, Glycemic Control and Complications in Type 2 Diabetes in General Practices (Disease Analyzer, Germany: 2008-2016)
Author(s): Rathmann W, Scheerer M, Rohwedder K, Busch S, Kostev K
Affiliations(s): 
Publication(s): 
Document Type(s): Article,
Countries: Germany,
C:
Y:
Diabetes,
2018
  L:
A:
English
  Add to report
 
 
 1 of 57 Next Page Last Page